Dimensional Fund Advisors
UBX

Dimensional Fund Advisors’s Unity Biotechnology UBX Stock Holding History

Dimensional Fund Advisors’s Portfolio UBX Stock Details UBX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-11,120
Closed -$11.6K – 3332
2025
Q1 		$11.6K Buy
+11,120
New +$20.1K ﹤0.01% 3314
2024
Q1 		– Sell
-25,500
Closed -$49.2K – 3432
2023
Q4 		$49.2K Sell
25,500
-14,219
-36% -$26.4K ﹤0.01% 3346
2023
Q3 		$95.3K Sell
39,719
-21,228
-35% -$56.2K ﹤0.01% 3319
2023
Q2 		$155K Sell
60,947
-6,952
-10% -$18.4K ﹤0.01% 3274
2023
Q1 		$111K Buy
67,899
+37,473
+123% +$150K ﹤0.01% 3289
2022
Q4 		$83 Buy
+30,426
New +$88.4K ﹤0.01% 3348
2022
Q1 		– Sell
-3,617
Closed -$53K – 3557
2021
Q4 		$53K Buy
3,617
+50
+1% +$1.09K ﹤0.01% 3492
2021
Q3 		$107K Sell
3,567
-1,333
-27% -$47K ﹤0.01% 3421
2021
Q2 		$227K Buy
4,900
+34
+0.7% +$1.64K ﹤0.01% 3316
2021
Q1 		$292K Buy
+4,866
New +$332K ﹤0.01% 3232

Other funds holding UBX

AVM
Arch Venture Management Chicago, Illinois $677M AUM 322.07% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
FFVM
Founders Fund V Management San Francisco, California $2.16M AUM 77.37% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Dimensional Fund Advisors's UBX Position: Q2 2025 in Review

Dimensional Fund Advisors sold out of Unity Biotechnology (UBX) in Q2 2025, closing a stake of 11,120 shares — an estimated $11.6K sold.

Dimensional Fund Advisors first reported a position in UBX in Q1 2021 and held it in 10 quarters. The position peaked at $292K in Q1 2021. 35 funds tracked by Wall St. Rank hold UBX as of Q2 2025.

  • Dimensional Fund Advisors reported no remaining Unity Biotechnology position as of Q2 2025 after selling out during the quarter.
  • Dimensional Fund Advisors sold 11,120 Unity Biotechnology shares in Q2 2025, an estimated $11.6K.
  • Dimensional Fund Advisors first reported a position in Unity Biotechnology in Q1 2021 and held it in 10 quarters.
  • Dimensional Fund Advisors's Unity Biotechnology position peaked at $292K in Q1 2021.
  • 35 funds tracked by Wall St. Rank held Unity Biotechnology as of Q2 2025.

Based on Dimensional Fund Advisors's 13F filing for Q2 2025, filed 12 Aug 2025.